{"id":"https://openalex.org/W3127636830","doi":null,"title":"Exploratory biomarkers in the HGF/SF:c-Met axis: preclinical and clinical results","display_name":"Exploratory biomarkers in the HGF/SF:c-Met axis: preclinical and clinical results","publication_year":2008,"publication_date":"2008-05-01","ids":{"openalex":"https://openalex.org/W3127636830","mag":"3127636830"},"language":"en","primary_location":{"id":"mag:3127636830","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/68/9_Supplement/2804","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001120662","display_name":"Angela Coxon","orcid":"https://orcid.org/0009-0000-3341-0645","observed_orcids":["https://orcid.org/0009-0000-3341-0645"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Coxon","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":"https://orcid.org/0009-0000-3341-0645","affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110070031","display_name":"Karen L. Rex","orcid":"https://orcid.org/0009-0008-5203-3476","observed_orcids":["https://orcid.org/0009-0008-5203-3476"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Rex","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103811382","display_name":"Jan Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan Sun","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023962655","display_name":"Jodi Moriguchi","orcid":"https://orcid.org/0009-0006-1980-6612","observed_orcids":["https://orcid.org/0009-0006-1980-6612"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jodi Moriguchi","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030814167","display_name":"Jennifer Malella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Malella","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107391673","display_name":"Mark Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Ma","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066558658","display_name":"Abraham Anderson","orcid":"https://orcid.org/0000-0002-1624-622X","observed_orcids":["https://orcid.org/0000-0002-1624-622X"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abraham Anderson","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yun Lan","orcid":"https://orcid.org/0000-0002-9783-4268","observed_orcids":["https://orcid.org/0000-0002-9783-4268"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun Lan","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":"https://orcid.org/0000-0002-9783-4268","affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069690249","display_name":"Michael S. Gordon","orcid":"https://orcid.org/0000-0002-7679-9504","observed_orcids":["https://orcid.org/0000-0002-7679-9504"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Gordon","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":"https://orcid.org/0000-0002-6212-6421","affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037169725","display_name":"Lia Gore","orcid":"https://orcid.org/0000-0002-2546-4616","observed_orcids":["https://orcid.org/0000-0002-2546-4616"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lia Gore","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":"https://orcid.org/0000-0002-2546-4616","affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002909668","display_name":"Christopher J. Sweeney","orcid":"https://orcid.org/0000-0002-0398-6018","observed_orcids":["https://orcid.org/0000-0002-0398-6018"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Sweeney","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113059801","display_name":"Lucy L. Yan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucy Yan","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002011167","display_name":"Darrin M. Beaupre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darrin M. Beaupre","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045016516","display_name":"Kelly Smith Oliner","orcid":"https://orcid.org/0009-0004-5986-2710","observed_orcids":["https://orcid.org/0009-0004-5986-2710"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly S. Oliner","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109359613","display_name":"Teresa L. Burgess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teresa L. Burgess","raw_affiliation_strings":["Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Inc., Thousand Oaks, CA, Premiere Oncology of Arizona, Scottsdale, AZ, University of Colorado, Aurora, CO, Indiana University of Medicine, Indianapolis, IN","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I4210146652"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4885,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.75468696,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"68","issue":null,"first_page":"2804","last_page":"2804"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.663100004196167,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.663100004196167,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.14499999582767487,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.07450000196695328,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9599999785423279},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.9229999780654907},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.796999990940094},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6940000057220459},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.7390000224113464},{"id":"https://openalex.org/keywords/patient-enrichment","display_name":"patient enrichment","score":0.6729999780654907},{"id":"https://openalex.org/keywords/cd44v6","display_name":"CD44v6","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-volume","display_name":"tumor volume","score":0.6309999823570251},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C2776996007","wikidata":"https://www.wikidata.org/wiki/Q2399112","display_name":"Hepatocyte growth factor","level":3,"score":0.8181776404380798},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6001808047294617},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5985686182975769},{"id":"https://openalex.org/C2780467284","wikidata":"https://www.wikidata.org/wiki/Q5005897","display_name":"C-Met","level":4,"score":0.5556480884552002},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5384291410446167},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.4918556213378906},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.48076102137565613},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43621766567230225},{"id":"https://openalex.org/C2777991845","wikidata":"https://www.wikidata.org/wiki/Q2396793","display_name":"Isotype","level":4,"score":0.4224264621734619},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4217725396156311},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4115251302719116},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.39781391620635986},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.363733172416687},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34324973821640015},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29556360840797424},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2697818875312805}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3127636830","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/68/9_Supplement/2804","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2148885898","https://openalex.org/W2161880708","https://openalex.org/W2800467932","https://openalex.org/W2076963287","https://openalex.org/W2134659609","https://openalex.org/W2134442967","https://openalex.org/W2150648786","https://openalex.org/W7096742315","https://openalex.org/W2081119236","https://openalex.org/W3010187320"],"abstract_inverted_index":{"2804":[0],"Introduction:":[2],"Hepatocyte":[3],"growth":[4,62],"factor":[5],"(HGF":[6],"-":[7],"also":[8,177,261],"known":[9],"as":[10,47,410,425],"Scatter":[11],"Factor":[12],"(SF))":[13],"and":[14,138,146,155,181,274,280,291],"its":[15,422],"receptor,":[16],"c-Met,":[17],"have":[18,52,376],"been":[19,199],"implicated":[20],"in":[21,42,91,170,187,191,218,248,255,263,267,310,351,396,419],"the":[22,61,68,92,171,219,253,311,322,341,366,416],"progression":[23],"of":[24,27,63,72,116,126,148,221,299,313,334,344,380,415],"several":[25],"types":[26],"cancers.":[28],"AMG":[29,127,172,202,241,258,319,335,348,361,388],"102":[30,128,173,203,242,259,336,349,362,389],"is":[31,40,350,369],"a":[32,48,123,245,264,306,327,370,393,411,426],"fully":[33],"human":[34,107,150,153,215,289],"monoclonal":[35],"antibody":[36,57,227],"to":[37,233,244,272,392,421],"HGF":[38,180,216,269,315,325,346,398,404],"that":[39,55,79,197,338,378,402],"currently":[41],"phase":[43],"2":[44],"clinical":[45],"trials":[46],"cancer":[49,385],"therapeutic.":[50],"We":[51,375],"previously":[53,237],"shown":[54,377],"this":[56],"can":[58],"significantly":[59],"inhibit":[60],"HGF-dependent":[64],"tumor":[65,230,249,256,296,381],"models,":[66],"including":[67],"U-87":[69,105],"MG":[70,106],"model":[71],"glioblastoma.":[73],"Here":[74],"we":[75,304],"examined":[76],"exploratory":[77],"biomarkers":[78],"might":[80],"be":[81],"useful":[82],"pharmacodynamic":[83],"or":[84,210,384],"patient":[85,427],"enrichment":[86,428],"markers":[87],"for":[88,413],"HGF/SF:c-Met":[89,367,417],"therapies":[90],"clinic.\u2028":[93],"Methods:":[94],"In":[95,286,301,321],"preclinical":[96],"experiments,":[97],"CD-1":[98],"nude":[99],"mice":[100,119,222,383],"were":[101,120,161,176,185],"injected":[102],"with":[103,122,201,224,229,240,295,318,360,387],"5x106":[104],"glioblastoma":[108],"cells.":[109],"When":[110],"tumors":[111],"reached":[112,326],"an":[113],"average":[114],"volume":[115,231],"475":[117],"mm3,":[118],"treated":[121,200,223],"single":[124],"dose":[125,193],"ranging":[129],"from":[130,167,189],"3-":[131],"300":[132],"\u00b5g":[133],"IP.":[134],"On":[135],"days":[136],"3":[137,279],"7":[139,282],"after":[140],"treatment":[141,239,260,317,379,407],"initiation,":[142],"plasma":[143,188,220,314,345],"was":[144],"harvested":[145],"levels":[147,184,217,293,312,343,356,405],"total":[149,268],"HGF,":[151],"soluble":[152,182,288],"c-Met":[154,158,183,290,355],"CD44v6":[156,292],"(a":[157],"associated":[159],"protein)":[160],"quantified":[162],"by":[163,329],"ELISA.":[164],"Plasma":[165],"samples":[166],"patients":[168,190,386],"enrolled":[169],"FIH":[174],"trial":[175],"examined.":[178],"Total":[179],"determined":[186],"sequential":[192],"cohorts":[194,324],"(4-6":[195],"pts/cohort)":[196],"had":[198],"at":[204,340],"0.5,":[205],"1,":[206],"3,":[207],"5,":[208],"10,":[209],"20":[211],"mg/kg.\u2028":[212],"Results:":[213],"Tumor-derived,":[214],"isotype":[225],"control":[226],"correlated":[228,294],"(133":[232],"399":[234],"pg/mL).":[235],"As":[236],"shown,":[238],"led":[243],"dose-dependent":[246,265,308,394],"reduction":[247,254],"volume.":[250],"However,":[251],"despite":[252],"mass,":[257],"resulted":[262],"increase":[266,309,395],"levels,":[270],"(up":[271],"1300":[273],"5476":[275],"pg/mL":[276],"on":[277],"day":[278,281,330],"post":[283],"treatment,":[284],"respectively).":[285],"contrast,":[287],"size,":[297],"regardless":[298],"treatment.":[300],"all":[302],"patients,":[303],"observed":[305],"similar":[307],"upon":[316],"102.":[320],"high-dose":[323],"plateau":[328],"8.":[331],"Pharmacokinetic":[332],"measurements":[333],"suggest":[337],"even":[339],"highest":[342],"measured,":[347],"great":[352],"excess.":[353],"Soluble":[354],"did":[357],"not":[358],"change":[359],"treatment.\u2028":[363],"Conclusions:":[364],"Targeting":[365],"axis":[368],"promising":[371],"oncology":[372],"therapeutic":[373],"strategy.":[374],"bearing":[382],"gives":[390],"rise":[391],"circulating":[397],"levels.":[399],"This":[400],"suggests":[401],"monitoring":[403],"during":[406],"may":[408],"serve":[409],"biomarker":[412],"inhibition":[414],"pathway,":[418],"addition":[420],"potential":[423],"utility":[424],"marker.":[429]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2021-02-15T00:00:00"}